Stephen W. Webster - 20 Jun 2024 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in-fact for Stephen W. Webster
Issuer symbol
NXTC
Transactions as of
20 Jun 2024
Net transactions value
$0
Form type
4
Filing time
21 Jun 2024, 17:05:08 UTC
Previous filing
20 Jun 2024
Next filing
27 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +18,700 $0.000000 18,700 20 Jun 2024 Common Stock 18,700 $1.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 20, 2025 and the date of the 2025 Annual Meeting of Stockholders.